Japan is the land of rising sun and it is the second largest economy for more than 40 years from 1968 to 2010. It is a fascinating country of economic and business prowess, rich culture, technically well-developed shares it boundaries with Korea, Russia and China. Japan consists of 6,852 islands. Geographically it is located in Pacific ring with continues series of ocean trenches, volcanic arcs and shifting tectonic plates. This Pacific ring consists of world’s 75 percent of Volcanoes and 90 percent of earthquakes. Areas wise the size of japan is equal to Germany or California with a population of around 127.3 million which stands tenth in the list.
After World War II ended in 1945, Japan made a new start toward economic reconstruction as a democratic and pacifist state. Japan succeeded in recovering from the ruins of war and achieving industrialization during the 1950s and 1960s. High economic growth prevailed from the mid-1960s through the 1970s with the arrival of a mass-consumption society, as technological innovations spurred the expansion of manufacturing facilities and sales of such consumer durables as television sets, refrigerators, and automobiles. It is on one among the among world's largest and most technologically advanced producers of motor vehicles, electronic equipment, machine tools, steel and nonferrous metals, ships, chemicals, textiles, processed foods.
Japan has established an R&D system for continuously creating global products and work on the creation of innovative new drugs. Pharma's drug discovery research is conducted at four research facilities within the Drug Research Division, i.e., Innovative Drug Discovery Laboratories which take charge of drug discovery , Drug Development Research Laboratories which promote research programs and projects quicker and more efficiently, Preclinical Research Laboratories which choose new drug compounds with additional high value and increase evaluation capacity of safety and pharmacokinetics, and Genomic Science Laboratories which support drug discovery research with leading-edge research technology.
Worldwide, most of the pharmaceutical R&D activity takes place in Organization for Economic Co-operation and Development (OCED). In 2011, the pharmaceutical industry spent close to USD 50 billion for R&D in the United States, 11.5 billion in Japan, 5.2 in Germany and 3.7 in France. 10 percent of private Research & Development was spent on pharmaceuticals in Japan. Spending on pharmaceutical industry was doubled in between 2000 and 2011. This growth was high in United States (+85%), followed by Japan (+76%) and Europe (+38%).